We will study whether blood cell levels of p11 differ between healthy individuals and patients with depression. Moreover, we will study whether the levels of p11 are affected by treatment with the selective serotonin reuptake inhibitor, citalopr...

Complementary work will continue at other laboratories to better characterize the role of p11 in the pathophysiology of depression (e.g., animal studies, post-mortem studies).

38

All

18 Years to 65 Years (Adult)

NCT00697268

08015008-M-0150

June 3, 2008

July 28, 2016

June 13, 2008

October 6, 2017

National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, Maryland, United States